Two Sigma Advisers’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-30,866
| Closed | -$1.4M | – | 2499 |
|
2024
Q3 | $1.4M | Sell |
30,866
-15,156
| -33% | -$687K | ﹤0.01% | 1256 |
|
2024
Q2 | $1.79M | Sell |
46,022
-5,969
| -11% | -$232K | ﹤0.01% | 1246 |
|
2024
Q1 | $1.68M | Sell |
51,991
-13,800
| -21% | -$445K | ﹤0.01% | 1315 |
|
2023
Q4 | $1.89M | Buy |
65,791
+12,691
| +24% | +$364K | ﹤0.01% | 1313 |
|
2023
Q3 | $1.47M | Sell |
53,100
-22,700
| -30% | -$628K | ﹤0.01% | 1354 |
|
2023
Q2 | $2.03M | Sell |
75,800
-99,900
| -57% | -$2.67M | 0.01% | 1195 |
|
2023
Q1 | $3.81M | Sell |
175,700
-3,900
| -2% | -$84.5K | 0.01% | 944 |
|
2022
Q4 | $4.28M | Sell |
179,600
-10,700
| -6% | -$255K | 0.01% | 848 |
|
2022
Q3 | $3.75M | Buy |
190,300
+83,100
| +78% | +$1.64M | 0.01% | 876 |
|
2022
Q2 | $2.09M | Sell |
107,200
-22,800
| -18% | -$444K | 0.01% | 1191 |
|
2022
Q1 | $3.32M | Buy |
130,000
+44,500
| +52% | +$1.14M | 0.01% | 994 |
|
2021
Q4 | $2.15M | Buy |
85,500
+19,600
| +30% | +$493K | 0.01% | 1153 |
|
2021
Q3 | $1.81M | Buy |
65,900
+56,200
| +579% | +$1.55M | ﹤0.01% | 1309 |
|
2021
Q2 | $308K | Buy |
9,700
+5,000
| +106% | +$159K | ﹤0.01% | 2133 |
|
2021
Q1 | $216K | Buy |
+4,700
| New | +$216K | ﹤0.01% | 2338 |
|